Clinical trial Recruiting at 1 site Observational Ages 18 and up

Free vitamin D and steroid metabolism in endocrine and kidney conditions

Official title: Free Fraction Vitamin D Measurements to Improve Understanding of Steroid Metabolism in Endocrine Disorders

Run by Universitaire Ziekenhuizen KU Leuven · NCT07268742 · Data updated 2026-11-12

This project will measure free (unbound) vitamin D and related steroid hormones in adults — including healthy people, pregnant women, and patients with endocrine or kidney disorders — to see how processing differs between groups.

More Vitamin D Deficiency trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment930 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven)
StatusRecruiting
StartedJune 1, 2024
Main results expectedOctober 2029
Study endsOctober 2029
Registry record updatedDecember 8, 2025
Trial IDNCT07268742 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who can consent and fit one of the study cohorts — healthy controls, people with BMI ≥25 kg/m² (obesity cohort), chronic kidney disease stage ≥3a, women in first-trimester pregnancy, patients with primary hyperparathyroidism scheduled for parathyroidectomy, or those with complex calcium/phosphate disorders — are ideal candidates.

Probably not a fit

People under 18, those unable to give informed consent, or individuals whose clinical profile does not match any cohort (for example those taking excluded vitamin D or calcium supplementation when applicable) are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects blood samples from adults across several cohorts (healthy controls, people with obesity, chronic kidney disease stage ≥3a, first-trimester pregnancy, primary hyperparathyroidism scheduled for surgery, and complex calcium/phosphate disorders) to measure free and total vitamin D and related steroid markers. Laboratory assays will quantify free vitamin D, total vitamin D, vitamin D binding protein, and selected steroid metabolites to characterize binding and metabolic patterns. The study compares these measures between groups to determine whether total vitamin D testing reflects biologically available free vitamin D in different clinical contexts. Findings are intended to clarify how vitamin D results should be interpreted in pregnancy and in various endocrine and renal disorders.

Why it matters

Potential benefit: If successful, this could help doctors interpret vitamin D tests more accurately and lead to better diagnosis and treatment for people with pregnancy, endocrine, or kidney conditions.

How similar studies have gone: Previous research on the free vitamin D or 'free hormone' hypothesis has produced promising but mixed results, so the approach is emerging but not yet an established clinical standard.

Who can join: the full rules

Show full inclusion / exclusion criteria
1. General inclusion Criteria:

   \- 18 years or above
2. General exclusion Criteria:

   * Below 18 years of age
   * Individuals incapable of providing informed consent
3. Cohort inclusion criteria

   * Obesity: BMI ≥ 25 kg/m2
   * Chronic Kidney Disease: ≥ CKD stage 3a (eGFR \< 60 mL/min/1.73m2)
   * Pregnancy: in trimester 1 of pregnancy
   * Primary hyperparathyroidism: diagnosis at UZ Leuven and scheduled for parathyroidectomy at UZ Leuven
   * Complex calcium and phosphate disorders: diagnosis at UZ Leuven
4. Cohort exclusion criteria

   * Healthy controls: BMI below 18 kg/m² or above 25 kg/m², pregnancy, chronic kidney disease (independent of staging), primary hyperparathyroidism and vitamin D and/or calcium supplementation
   * Obesity: chronic kidney disease (independent of staging), pregnancy, primary hyperparathyroidism
   * Chronic Kidney Disease: BMI below 18 kg/m² or above 30 kg/m², pregnancy, primary hyperparathyroidism
   * Pregnancy: BMI below 18 kg/m² or above 30 kg/m², chronic kidney disease (independent of staging), primary hyperparathyroidism
   * Primary hyperparathyroidism: BMI below 18 kg/m² or above 30 kg/m², pregnancy, chronic kidney disease (independent of staging), secondary hyperparathyroidism

Where it's running

  • University Hospitals Leuven
    Leuven, Belgium
    Recruiting

Study contacts

  • Principal investigator: Leen Antonio, MD, PhD — University Hospitals Leuven, Department of Endocrinology
  • Study coordinator: Nick Narinx, MD
  • Email: nick.narinx@uzleuven.be
  • Phone: +3216348516

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.